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SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comScientiﬁc), and 60MHz IVUS (Kodama, ACIST Medical Systems) in a saline-ﬁlled
tank at 37C. In each diameter phantom model, mean lumen diameter (mean LD) was
obtained at 10 cross-sections randomly selected from 3 repeated automated pullbacks.
OCT images were obtained under the system setting for saline ﬂush. IVUS mea-
surements were adjusted to compensate for the difference in the speed of sound in
saline vs. blood.
Results: Overall, OCT and 40MHz IVUS consistently overestimated mean LD
(0.070.03 and 0.150.03 mm, respectively), while 60MHz IVUS showed slight
underestimation (-0.080.03 mm). In all diameter models, absolute differences in
mean LD were signiﬁcantly larger in 40MHz IVUS than OCT and 60MHz IVUS
(p< 0.01 for all). 60MHz IVUS was comparable or superior to OCT in phantoms
S3.04 mm, whereas OCT showed excellent near-ﬁeld precision in small diameter
phantoms (&2.03 mm).Mild calciﬁcation Heavy calciﬁcation
Arc of calciﬁcation (0x90 ) Arc of calciﬁcation (90x360 )
EES (N¼22) BES (N¼17) P EES (N¼39) BES (N¼34) P
Mean arc of calciﬁcation ( ) 55.6820.22 55.3414.11 0.954 174.2269.74 190.9091.21 0.390
DM (%) 13.6 17.6 0.739 53.8 61.8 0.502
Pre % diameter stenosis 69.2 69.6 0.916 69.6 69.1 0.890
Just after stenting
Minimum/Estimated stent
diameter (mm)
0.764 0.781 0.388 0.713 0.750 0.111
Minimum/Estimated CSA
(mm2)
0.713 0.773 0.044 0.651 0.748 <0.01
Symmetry index 0.873 0.876 0.873 0.813 0.862 <0.01
Final resul
Minimum/Estimated stent
diameter (mm)
0.793 0.837 0.07 0.741 0.789 0.037
Minimum/Estimated CSA
(mm2)
0.764 0.784 0.516 0.731 0.792 0.011
Symmetry index 0.878 0.881 0.907 0.843 0.871 0.057Conclusions: The novel 60MHz IVUS system signiﬁcantly improves the quantitative
accuracy of conventional 40MHz IVUS, demonstrating clinically acceptable precision
across the wide range of lumen diameter from 1.5 to 5.0 mm.
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Background: Although it has been recognized that thin strut cobalt chromium
everolimus-eluting stent (EES; Xience) is associated with less target lesion failure, it
has lower radial force, and it had failed to prove superiority to thick strut paclitaxel-
eluting stent in diabetes in some studies. We speculated that stent underexpansion in
calciﬁed lesions which are frequently observed in diabetes may be one of reasons, and
investigated stent expansion between two different types of stent platform in calciﬁed
lesions using intravascular ultrasound (IVUS).B106 JACC Vol 64/11/Suppl B jMethods: One hundred twelve lesions (61 EES and 51 thick stainless platform bio-
limus-eluting stent (BES; Nobori) treated by IVUS-guided elective PCI were
recruited. With pre-procedural IVUS, optimal stent size and length were determined
and degree of calciﬁcation was evaluated. After stenting, IVUS was repeated and stent
diameter and cross-sectional area (CSA) were measured. If stent expansion was
inadequate, post dilatation was performed and again IVUS was performed. Quanti-
tative coronary angiography (QCA) and IVUS ﬁndings were compared with estimated
diameter and CSA calculated from deployed pressure and each compliance chart
(Measured/Estimated ratio).
Results: Immediately after stenting in moderate/severe calciﬁed lesions (arc of
calciﬁcation > 90 degree), underexpansion of EES compared to BES was observed,
and the trend continued after post dilatation.Conclusions: There is a signiﬁcant difference of expansion between thin cobalt and
thick stainless stents in calciﬁed lesions. When thin strut stent is deployed in calciﬁed
lesions, careful evaluation of stent expansion and adequate post dilatation may be
necessary.Imaging Intravascular - OCT
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Background: Lack of re-endothelialisation and neointimal coverage on stent struts
has been put forward as the main underlying mechanism leading to late stent
thrombosis. Incomplete Stent Apposition (ISA) has been frequently observed in pa-
tients with very late stent thrombosis after DES implantation, suggesting a role of ISA
in the pathogenesis of this adverse event. The aim of this study was to evaluate the
impact of different degrees of ISA severity on abnormal shear rate and healing
response with coverage, due to its potential implications for stent optimization in
clinical practice.
Methods: We characterized ﬂow proﬁle and shear distribution in different cases of
ISA with increasing strut-wall detachment distance (ranging from 100 mm to 500 mm).
Protruding strut and strut malapposed with moderate detachment (ISA detachment
distance < 100mm) have minimal disturbance to blood ﬂow as compared with ﬂoating
strut that has more signiﬁcant ISA distance. In-vivo impact on strut coverage was
assessed retrospectively using Optical Coherence Tomography evaluation on 72 stents
(48 patients) sequentially at baseline and after 6 months follow-up.September 13–17, 2014 j TCT Abstracts/Imaging Intravascular - OCT
www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PMResults: Analysis of coverage revealed an important impact of baseline strut-wall ISA
distance on the risk of incomplete strut coverage at follow-up. Malapposed segments
with an ISA detachment < 100 mm at baseline showed complete strut coverage at
follow-up whereas segments with a maximal ISA detachment distance of 100-300 mm
and >300 mm had 6.1 % and 15.7% of their struts still uncovered at follow-up
respectively (p < 0.001).
Conclusions: Flow disturbances and risk of delayed strut coverage both increase with
ISA detachment distance. Insights from this study are important for understanding
malapposition as a quantitative, rather than binary phenomenon (present or absent),
and to deﬁne the threshold of ISA detachment that might beneﬁt from optimization
during stent implantation.
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Background: Rupture of atherosclerotic plaque and resulting thrombosis is the basis
for acute coronary syndrome (ACS). Standard arteriography is commonly used to
guide percutaneous treatment of ACS but it has limited ability to detect thrombus or
plaque rupture site. Intravascular ultrasound (IVUS) has improved capabilities to
detect these lesions. However, optical coherence tomography (OCT) is more sensitive
than IVUS in detecting thrombus and plaque rupture site which can potentially
improve stent positioning.
Methods: Retrospective review of OCT images in 46 patients who presented with
ST-elevation myocardial infarction (STEMI) and non-ST elevation myocardial
infarction (NSTEMI) was performed. The plaque rupture site and thrombus were
identiﬁed and the distance from the two were measured.
Results: Plaque rupture site was identiﬁed in 80% of cases. Thrombus was identiﬁed
in 89% of STEMI cases and 67% of NSTEMI cases (n¼0.09). One patient had the
thrombus upstream, one patient had it at the rupture site, and the remaining 44 patients
had it downstream to the plaque rupture site. Mean distance between the thrombus and
plaque rupture site is shown in graph.Conclusions: OCT has good sensitivity in identifying plaque rupture site and
thrombus in patients with STEMI and NSTEMI. The mean distance between the
plaque rupture site and the thrombus was 5.1 mm suggesting that using standard
arteriography to guide stenting may lead to suboptimal treatment since the stent can
cover the thrombotic site but miss the plaque rupture site that remains thrombogenic.
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Background: The beneﬁts of the ﬁrst available “dual” therapy approach endothelial-
progenitor-cell capturing sirolimus-eluting stent (COMBO Stent, OrbusNeich Medi-
cal, FL, USA) were studied.JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/ImMethods: Using 4 longitudinal sequential OCTs in this prospective, single center
study, 61 patients treated by COMBO Stent had baseline OCT (for optimal stent
apposition), at early FUs (4 monthly groups in 1:2:2:1 ratio from 2nd to 5th month for
healing proﬁle [% strut coverage] using 6 Categories), at 9M (for neointima), and a
ﬁnal 24M OCT (for late loss outcomes). Clinical event adjudication, angiographic and
OCT analyses were performed by CRF core laboratory.
Results: 61 patients (33% DM) with 74 lesions received 88 COMBO stents. Early
strut coverage (OCT Cat. D to F) increased from 77, 86.9, 90.7, to 92.5%; interpolated
100% coverage at 150 days. 9M OCT FU Rate was 100% & TLR at 1.64%. 24M OCT
FU Rate was 68.3%; at 38M (Clinical FU Rate 98.3%) MACE Rate was 3.28%. From
9 to 24 months, neointima regression by OCT was observed:- (Mixed Model, Median,
IQR) neointimal thickness (mm) 0.14 [0.08, 0.21] vs 0.12 [0.07, 0.19], p< 0.001;
neointimal volume (mm3) 29.91 [22.13-43.22] vs 26.17 [19.94-35.81], p¼0.003;
& in-stent % plaque volume (%) 17.76 [12.21-21.22] vs 15.65 [11.17-19.35],
p¼0.011. No neoatherosclerosis or ARC deﬁnite or probable LST recorded.
Conclusions: This OCT Study demonstrates the beneﬁts of the “dual” therapy DES
approach, with excellent pro-healing proﬁle established translating into durable out-
comes of neointimal suppression (even 24M regression, for the ﬁrst time in a DES)
without late stent failure.TCT-368
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Background: After implantation of an everolimus-eluting poly-l-lactic-acid scaffold
(Absorb BVS, Abbott Vascular, Santa Clara, CA), the strut is progressively hy-
drolyzed and integrated into the arterial wall. The quantitative light intensity anal-
ysis of the strut core on Optical Coherence Tomography (OCT) enables us to assess
the light reﬂectivity of the resorbing polymer and its vessel wall integration. The aim
of this study was to compare this quantitative method with histology in porcine
model.
Methods: Seventy-six BVS were implanted in 51 pigs that underwent OCT and were
then euthanized at 3, 6, 12, 18, 24, 30 and 36 months after implantation. On OCT, the
median light intensity value of strut was calculated by dedicated software, which was
normalized by the intensity value of inter-strut neointima. On histology, integration
grade of the corresponding struts was classiﬁed into 5 groups according to the con-
nective tissue composition.
Results: A total of 275 struts were analyzed. The normalized light intensity value
(NLIV) increased steadily over time except between 12 and 18 months. (0.15 [0.12-
0.20] at 6M, 0.19 [0.15-0.25] at 12M, 0.20 [0.15-0.25] at 18M, 0.23 [0.18-0.32] at
24M, 0.32 [0.24-0.44] at 30M, and 0.52 [0.35-0.76] at 36M). As the integration grade
progresses in histology, NLIV increased gradually (Figure).
Conclusions: The OCT NLIV might be valuable for monitoring the integration
process of polymeric bioresorbable scaffolds. Histological and imaging analysis at
42 and 48 months are ongoing. The full results will be shown at the time of the
meeting.aging Intravascular - OCT B107
